tallózása szerző szerint "Gyulavári, Pál"

1-8 / 8

Discovery and biological evaluation of novel dual EGFR/c-Met inhibitors

Szokol, Bálint; Gyulavári, Pál; Kurkó Ibolya,; Baska, Ferenc; Szántai-Kis Csaba,; Peták, István; Pénzes, Kinga; Őrfi, László; Vántus, Tibor; Kéri, György (2014)
Discovery and optimization of novel benzothiophene-3-carboxamides as highly potent inhibitors of Aurora kinases A and B

Gyulavári, Pál; Szokol, Bálint; Szabadkai, István; Brauswetter, Diána; Bánhegyi, Péter; Varga, Attila; Markó, Péter; Boros, Sándor; Illyés, Eszter; Szántai-Kis, Csaba; Krekó, Marcell; Czudor, Zsófia; Őrfi, László (2018)
Discovery of N-[4-(Quinolin-4-yloxy)phenyl]benzenesulfonamides as Novel AXL Kinase Inhibitors

Szabadkai, I; Torka, R; Garamvölgyi, Rita; Baska, Ferenc; Gyulavári, Pál; Boros, Sándor; Illyes, E; Choidas, A; Ullrich, A; Őrfi, László (2018)

The overexpression of AXL kinase has been described in many types of cancer. Due to its role in proliferation, survival, migration, and resistance, AXL represents a promising target in the treatment of the disease. In this ...
In vitro imaging and quantification of the drug targeting efficiency of fluorescently labeled GnRH analogues

Murányi, József; Varga, Attila; Gurbi, Bianka; Gyulavári, Pál; Mező, Gábor; Vántus, Tibor (2017)

GnRH analogues are effective targeting moieties and able to deliver anticancer agents selectively into malignant tumor cells which highly express GnRH receptors. However, the quantitative analysis of GnRH analogues’ cellular ...
Novel Crizotinib–GnRH conjugates revealed the significance of lysosomal trapping in GnRH-based drug delivery systems

Murányi, József; Varga, Attila; Gyulavári, Pál; Pénzes, Kinga; Németh, Csilla Emese; Csala, Miklós; Pethő, Lilla; Csámpai, Antal; Halmos, Gábor; Peták, István; Vályi-Nagy, István (2019)

Several promising anti-cancer drug–GnRH (gonadotropin-releasing hormone) conjugates have been developed in the last two decades, although none of them have been approved for clinical use yet. Crizotinib is an effective ...
Novel kinase inhibitor compounds for combination cancer therapy

Gyulavári, Pál (2019)
Synthesis, characterization and systematic comparison of FITC-labelled GnRH-I, -II and -III analogues on various tumour cells

Murányi, József; Gyulavári, Pál; Varga, Attila; Bökönyi G,; Tanai H,; Vántus, Tibor; Ludányi, Krisztina; Mező, Gábor; Kéri, György (2016)

Targeted tumour therapy is the focus of recent cancer research. Gonadotropin-releasing hormone (GnRH) analogues are able to deliver anticancer agents selectively into tumour cells, which highly express GnRH receptors. ...
The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers–In Vitro Studies

Gurbi, Bianka; Brauswetter, Diána; Varga, Attila; Gyulavári, Pál; Pénzes, Kinga; Murányi, József; Zámbó, Veronika; Birtalan, Ede; Krenács, Tibor; Becker, David Laurence; Csala, Miklós; Vályi-Nagy, István; Peták, István; Dános, Kornél (2019)

1-8 / 8

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban

Hozzáférésem

Bejelentkezés

tallózása szerző szerint "Gyulavári, Pál"

DSpace/Manakin Repository

tallózása szerző szerint "Gyulavári, Pál"

Keresés

Tallózás

Teljes repozitórumban

Hozzáférésem